Publications Database

Guastella A. J. et al. (2015)

The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.

Journal of Child Psychology and Psychiatry

April, 56(4), pp. 444-452.

Read Abstract (New Window)

Handen B. L. et al. (2015)

Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention deficit hyperactivity disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

November, 54(11), pp. 905-915.

Read Abstract (New Window)

Handen B. L. , Johnson C. R. , Lubetsky M. J. (2000)

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Journal of Autism and Developmental Disorders

30(3), pp. 245-255

Read Abstract (New Window)

Handen B. L. , Sahl R. , Hardan A. Y. (2008)

Guanfacine in children with autism and/or intellectual disabilities.

Journal of Developmental and Behavioral Pediatrics

29(4), pp. 303-308

Read Abstract (New Window)

Handen B. L. et al. (2011)

Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.

Journal of Child and Adolescent Psychopharmacology

February, 21(1), pp. 43-50

Read Abstract (New Window) Read Full (New Window)

Hardan A. Y. et al. (2012)

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

Biological Psychiatry

71(11), pp. 956-961.

Read Abstract (New Window)

Harfterkamp M. et al. (2012)

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

5(7), pp. 733-741.

Read Abstract (New Window)

Harfterkamp M. et al. (2014)

Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change.

Journal of Child and Adolescent Psychopharmacology

November, 24(9), pp. 481-485.

Read Abstract (New Window)

Harfterkamp M. et al. (2013)

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: An open-label extension study.

Journal of Child and Adolescent Psychopharmacology

23(3), pp. 194-199.

Read Abstract (New Window)

Hellings J. A. et al. (2001)

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 229-238

Read Abstract (New Window)

Hendren. R. L. et al.

Randomized, placebo-controlled trial of methyl B12 for children with autism.

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Hess L. G. et al.

A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with Fragile X syndrome.

Journal of Developmental and Behavioral Pediatrics

Read Abstract (New Window)

Hollander E. et al. (2006)

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder

Journal of Child and Adolescent Psychopharmacology

16 pp. 541-548

Read Abstract (New Window)

Hollander E. et al. (2012)

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

American Journal of Psychiatry

169(3), pp. 292-299.

Read Abstract (New Window)

Hollander E. et al. (2006)

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.

International Journal of Neuropsycholpharmacology

9(2), pp. 209-213

Read Abstract (New Window)

Hollander E. et al. (2007)

Oxytocin increases retention of social cognition in autism.

Biological Psychiatry

61(4), pp. 498-503

Read Abstract (New Window) Read Full (New Window)

Hollander E. et al. (2003)

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

Neuropsychopharmacology

28 pp. 193-198

Read Abstract (New Window) Read Full (New Window)

Hyman S. L. et al. (2016)

The gluten-free, casein-free diet: a double-blind challenge trial in children with autism.

Journal of Autism and Developmental Disorders

January, 46(1), pp. 205-220.

Read Abstract (New Window)

Ichikawa H. et al.

Aripiprazole in the treatment of irritability in children and adolescents with autism spectrum disorder in Japan: A randomized, double-blind, placebo-controlled study.

Child Psychiatry and Human Development

Read Abstract (New Window)

Jahromi L. B. et al. (2009)

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.

Journal of Autism and Developmental Disorders

39(3), pp. 395-404

Read Abstract (New Window)